Evaluation of seroprevalence of Hepatitis B virus infection among patients attending a hospital of semi-urban North India using rapid immunoassay test

Niger Postgrad Med J. 2016 Oct-Dec;23(4):209-214. doi: 10.4103/1117-1936.196263.

Abstract

Background: Viral hepatitis is a serious public health problem with hepatitis B virus (HBV) being one of its principle causes affecting billions of people globally. The laboratory diagnosis of HBV infection is made by detection of hepatitis B surface antigen (HBsAg) in serum.

Objective: The present study was done to evaluate the seroprevalence of hepatitis B infection among patients attending a hospital at a semi-urban North India using rapid immunoassay test kit.

Materials and methods: A total of 1537 patients were included in the study whose venous blood samples were collected, and serum was tested for the presence of HBsAg using a rapid one-step immunoassay test kit.

Results: Out of 1537 patients whose blood samples were tested, 61 were found to be reactive to HBsAg giving the prevalence to be 3.9%, with 49 males and 12 females. Out of 61 reactive patient's majority belonged to inpatient (82.0%) as compared to outpatient department (18.0%). The majority of the reactive patients belonged to age group 28-37 years (37.7%), belonged to rural areas (86.9%), were illiterate (67.2%), were skilled workers (63.9%) and belonged to socioeconomic Class 4 (50.8%). Among the reactive patients, the most frequent suspected risk factor for hepatitis B infection was found to be visiting a community barber (19.7%).

Conclusion: HBV infection is a dreadful disease, and its accurate and timely diagnosis using rapid immunoassay test kit is useful as it gives an indication about its seroprevalence in a given geographical area even with limited resources.

MeSH terms

  • Female
  • Hepatitis B / epidemiology*
  • Hepatitis B Antibodies / analysis*
  • Hepatitis B Surface Antigens
  • Hepatitis B virus
  • Humans
  • Immunoassay
  • India / epidemiology
  • Male
  • Nigeria
  • Prevalence
  • Seroepidemiologic Studies

Substances

  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens